324 related articles for article (PubMed ID: 16787915)
21. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
Tanaka T; Nangaku M
Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872
[TBL] [Abstract][Full Text] [Related]
22. Cerebral adaptations to chronic anemia in a model of erythropoietin-deficient mice exposed to hypoxia.
El Hasnaoui-Saadani R; Pichon A; Marchant D; Olivier P; Launay T; Quidu P; Beaudry M; Duvallet A; Richalet JP; Favret F
Am J Physiol Regul Integr Comp Physiol; 2009 Mar; 296(3):R801-11. PubMed ID: 19109375
[TBL] [Abstract][Full Text] [Related]
23. A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4.
Makita T; Hernandez-Hoyos G; Chen TH; Wu H; Rothenberg EV; Sucov HM
Genes Dev; 2001 Apr; 15(7):889-901. PubMed ID: 11297512
[TBL] [Abstract][Full Text] [Related]
24. Herpesvirus entry mediator regulates hypoxia-inducible factor-1α and erythropoiesis in mice.
Sakoda Y; Anand S; Zhao Y; Park JJ; Liu Y; Kuramasu A; van Rooijen N; Chen L; Strome SE; Hancock WW; Chen L; Tamada K
J Clin Invest; 2011 Dec; 121(12):4810-9. PubMed ID: 22080867
[TBL] [Abstract][Full Text] [Related]
25. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality.
Suzuki N; Ohneda O; Takahashi S; Higuchi M; Mukai HY; Nakahata T; Imagawa S; Yamamoto M
Blood; 2002 Oct; 100(7):2279-88. PubMed ID: 12239135
[TBL] [Abstract][Full Text] [Related]
26. IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation.
Wilkinson N; Pantopoulos K
Blood; 2013 Aug; 122(9):1658-68. PubMed ID: 23777768
[TBL] [Abstract][Full Text] [Related]
27. Functional conservation of erythropoietin signaling in zebrafish.
Paffett-Lugassy N; Hsia N; Fraenkel PG; Paw B; Leshinsky I; Barut B; Bahary N; Caro J; Handin R; Zon LI
Blood; 2007 Oct; 110(7):2718-26. PubMed ID: 17579187
[TBL] [Abstract][Full Text] [Related]
28. STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Wincewicz D; Sulkowski S
Folia Histochem Cytobiol; 2009 Jan; 47(3):425-30. PubMed ID: 20164027
[TBL] [Abstract][Full Text] [Related]
29. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis.
Forejtnikovà H; Vieillevoye M; Zermati Y; Lambert M; Pellegrino RM; Guihard S; Gaudry M; Camaschella C; Lacombe C; Roetto A; Mayeux P; Verdier F
Blood; 2010 Dec; 116(24):5357-67. PubMed ID: 20826723
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.
Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735
[TBL] [Abstract][Full Text] [Related]
31. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.
Kapitsinou PP; Liu Q; Unger TL; Rha J; Davidoff O; Keith B; Epstein JA; Moores SL; Erickson-Miller CL; Haase VH
Blood; 2010 Oct; 116(16):3039-48. PubMed ID: 20628150
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin production in neuroepithelial and neural crest cells during primitive erythropoiesis.
Suzuki N; Hirano I; Pan X; Minegishi N; Yamamoto M
Nat Commun; 2013; 4():2902. PubMed ID: 24309470
[TBL] [Abstract][Full Text] [Related]
33. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
Han Y; Gao C; Liu Y; Zhang H; Wang S; Zhao H; Bao W; Guo X; Vinchi F; Lobo C; Shi P; Mendelson A; Luchsinger L; Zhong H; Yazdanbakhsh K; An X
Blood; 2024 Mar; 143(11):1018-1031. PubMed ID: 38127913
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
35. STAT3, HIF-1alpha, EPO and EPOR - signaling proteins in human primary ductal breast cancers.
Wincewicz A; Sulkowska M; Koda M; Leśniewicz T; Kanczuga-Koda L; Sulkowski S
Folia Histochem Cytobiol; 2007; 45(2):81-6. PubMed ID: 17597020
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin and co.: intrinsic structure and functional disorder.
Uversky VN; Redwan EM
Mol Biosyst; 2016 Dec; 13(1):56-72. PubMed ID: 27833947
[TBL] [Abstract][Full Text] [Related]
37. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
39. Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis.
Chang HC; Huang DY; Wu MS; Chu CL; Tzeng SJ; Lin WW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):687-696. PubMed ID: 28131718
[TBL] [Abstract][Full Text] [Related]
40. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
